TGFB2 and central nervous system cancer: Bioinformatic analysis of transforming growth factor beta 2 (TGFB2) mRNA has revealed its significant role as a negative prognostic marker in low-grade glioma, where mRNA levels of TGFB2 are upregulated in low-grade glioma (LGG) tumors and correlated with poorer overall survival outcomes.